Wilms' tumor 1 (WT1) expression and prognosis in solid cancer patients: a systematic review and meta-analysis | Scientific Reports
Cancers | Free Full-Text | TERT Expression in Wilms Tumor Is Regulated by Promoter Mutation or Hypermethylation, WT1, and N-MYC
Identification of Nephrogenic Therapeutic Biomarkers of Wilms Tumor Using Machine Learning
Wilms tumour | Nature Reviews Disease Primers
Identification of the potential novel biomarkers as susceptibility gene for Wilms tumor | BMC Cancer | Full Text
Wilms' Tumour – Histology and Differential Diagnosis - Wilms Tumor - NCBI Bookshelf
Pathology of Wilms' tumour in International Society of Paediatric Oncology (SIOP) and Children's oncology group (COG) renal tumour studies: Similarities and differences - Vujanić - 2022 - Histopathology - Wiley Online Library
Tumor-Specific Markers and Their Staining Pattern* | Download Table
Wilms' Tumour – Histology and Differential Diagnosis - Wilms Tumor - NCBI Bookshelf
Systematic review of the immunological landscape of Wilms tumors: Molecular Therapy - Oncolytics
Frontiers | Identification of a 12-Gene Signature and Hub Genes Involved in Kidney Wilms Tumor via Integrated Bioinformatics Analysis
Bilateral Wilms tumour (BWT) is frequently associated with germline... | Download Scientific Diagram
The UMBRELLA SIOP–RTSG 2016 Wilms tumour pathology and molecular biology protocol | Nature Reviews Urology
Wilms' Tumour – Histology and Differential Diagnosis - Wilms Tumor - NCBI Bookshelf
Biomarkers to detect Wilms tumors in pediatric patients: where are we now? | Future Oncology
Frontiers | MicroRNA Profiling in Wilms Tumor: Identification of Potential Biomarkers
Genetic Events in the Development of Wilms' Tumor | NEJM
Conditions with an increased risk of Wilms tumour | Download Table
Wilms tumor
Gene expression studies of WT1 mutant Wilms tumor cell lines in the frame work of published kidney development data reveals their early stem cell origin | bioRxiv
Alternative tumour-specific antigens | Nature Reviews Cancer
Outcome and Prognostic Factors in Stage III Favorable-Histology Wilms Tumor: A Report From the Children's Oncology Group Study AREN0532 | Journal of Clinical Oncology
Podocyte lineage marker expression is preserved across Wilms tumor subtypes and enhanced in tumors harboring the SIX1/2 p.Q177R mutation | bioRxiv
